Sinocelltech Group Limited (SHA:688520)
China
· Delayed Price · Currency is CNY 39.36
-0.53 (-1.33%)
At close: Mar 9, 2026
Sinocelltech Group Revenue
In the year 2025, Sinocelltech Group had annual revenue of 1.56B CNY, down -37.91%. Sinocelltech Group had revenue of 248.27M in the quarter ending December 31, 2025, a decrease of -56.88%.
Revenue
1.56B
Revenue Growth
-37.91%
P/S Ratio
11.24
Revenue / Employee
685.18K
Employees
2,242
Market Cap
17.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.56B | -952.56M | -37.91% |
| Dec 31, 2024 | 2.51B | 625.36M | 33.13% |
| Dec 31, 2023 | 1.89B | 864.17M | 84.46% |
| Dec 31, 2022 | 1.02B | 888.78M | 661.33% |
| Dec 31, 2021 | 134.39M | 134.06M | 40,852.82% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BrightGene Bio-Medical Technology | 1.22B |
| Jinyu Bio-technology | 1.33B |
| Anhui Anke Biotechnology (Group) | 2.58B |
| Inner Mongolia Furui Medical Science | 1.47B |
| Suzhou Zelgen Biopharmaceuticals | 812.73M |
| Tibet Cheezheng Tibetan Medicine | 2.42B |
| Vcanbio Cell & Gene Engineering Corp., | 1.47B |
| Mabwell (Shanghai) Bioscience | 662.52M |